1.Application of non-fusion inter-spinous stabilization devices in the treatment of low back pain
Chinese Journal of Tissue Engineering Research 2007;11(32):6502-6504
OBJECTIVE: To understand the research on the development and application of non-fusion inter-spinous stabilization devices.DATA SOURCES: Using the key terms of "inter-spinous and low back pain", relevant articles on non-fusion inter-spinous stabilization devices and low back pain in English were retrieved from Medline between January 1966 and October 2004 and the Ovid database between January 2003 and June 2007.STUDY SELECTION: Titles and most abstracts of all articles on the types of non-fusion inter-spinous stabilization devices and action mechanisms of non-fusion inter-spinous stabilization devices were selected. Duplicated researches and meta analytic papers were excluded.DATA EXTRACTION: A total of 351 articles met the inclusion criteria and 322 were excluded. Among them, 29 papers were analyzed. The major exclusion factor was duplicate studies.DATA SYNTHESIS: Non-fusion inter-spinous stabilization devices can improve mechanism of low back pain and cause certain effects on the biodynamic environment of degenerative lumbar vertebrae, such as relieving loading of the posterior border of the anulus fibrosus of the intervertebral disc and opening the intervertebral foramen. At present,non-fusion inter-spinous stabilization devices, such as X-STOP, Wallis and DLAM, have been tested for a long time;therefore, the effects of their effectiveness, utility and risk of complications will be proved by clinical experiments as soon as possible.CONCLUSION: Non-fusion inter-spinous stabilization devices have good effects on the treatment of degenerative low back pain originating in the anulus fibrosus of the intervertebral disc and can reduce complications caused by the fusion technique.
2.Radionucide and vehicle as well as radiation synovectomy
Chinese Journal of Tissue Engineering Research 2007;11(5):997-1000
OBJECTIVE: To investigate the selections of radionucide and vehicle and the indications, contraindications, complications and cautions of radiation synovectomy in clinical applications; meanwhile, to provide valuable references for clinical application of radiation synovectomy.DATA SOURCES: Of 277 articles which have the word "radiation synovectomy" or "radiosynovectomy" were searched out from PubMed database without limitations.STUDY SELECTION: All the titles and most abstracts of the articles were reviewed. A total of 58 articles were selected by the standard of having close relations with radionucide, vehicle and radiation synovectomy. Then the full texts were searched in other available databases, especially in "OVID" and "ScienceDirect".DATA EXTRACTION: The last articles and articles published in authority journals were chosen for further read, and 41 articles were obtained.DATA SYNTHESIS: Recently, the hot topic of radionucide is detailed as follows: Firstly, selection of vehicle. Till now, silicate, citrate, Ca oxalate, ferric hydroxide macroaggregate (FHMA), hydroxyapatite (HA), polylactic acid (PLA), sulfur colloids, microspheres, etc. Have been the most widely used vehicles. The usage of a good vehicle is to control the size and stability of the radiopharmaceutical, and decrease its leakage from the joint. Secondly, it should contain radiopharmaceuticals of nuclein and vehicle. An ideal radiolabeled radiopharmaceutical for radiation synovectomy should meet the following requirements: ① it should be sufficiently small to be phagocytized, but not so small that it might leak from the joint before being phagocytized, the appropriate size range is usually considered to be from 2 to 10 μm; ② the binding between the radionuclide and the vehicle should be irreversible throughout the course of the radiotherapy, which, in turn, is determined by the physical half-life of the radionuclide; ③ the radiolabeled particles should be distributed homogeneously in the joint without initiating an inflammatory response; ④ the half-life of the vehicle should be longer than that of the nuclide it combines,and the vehicle should be biodegradable, so that it can be eliminated out of the body after therapy; ⑤ good stability and low cost are also very important features. Thirdly, Radiation synovectomy is an effective method to treat chronic arthritis.CONCLUSION: With careful nuclide and indication selection and correct operation, radiation synovectomy is a clinically useful, safe, and cost-effective outpatient procedure in the treatment for many kinds of joint disease.
3.Clinical analysis of upper gastrointestinal hemorrhage in elderly patients and young-middle-aged patients
Chinese Journal of Primary Medicine and Pharmacy 2009;16(7):1233-1234
Objective To investigate the characteristics of clinical course in elderly patients and young-mid-dle-aged patients with upper gastrointestinal hemorrhage. Methods 417 hospitalized patients were divided into eld-edy group (≥60 yrs,198 cases) and young-middle-aged( <60 yrs,219 cases). All patients were diagnosed upper gastrointestinal hemorrhage by endoscopy. Results Endoscopy diagnosis included the first common cause to upper gastrointestinal hemorrhage was peptic ulcer, whereas more gastric ulcer were seen in elderly patients and more duo-denal ulcer were seen in young-middle-aged patients(23.7% vs 12.8%, 39.7% vs 21.7%, P <0.01). More eld-erly patients had a history of using Aspirin or NSMDs (17.1% vs 5.0%, P <0.01). The number of circulatory fail-ure and blood transfusion necessary were significantly increased, the mean duration of hospital stay was longer in eld-erly group than in young-middle-aged group(P<0.05). Conclusion The elderly patients have a more complicated clinical course than those young-mlddle-aged patients. Endoscopy is a necessary and effective method for both diagno-sis and treatment.
4.Role and mechanism of XRCC4 in the genesis and development of tumor
International Journal of Surgery 2013;40(10):699-702
DNA double-strand breaks(DSBs) repair protein XRCC4,plays an important role in the genesis and development of tumor,there are many different aspects in the tumor genesis and development.This paper reviews the molecular mechanism of XRCC4 in repairing DSBs,several theories of tumor genesis and development,and the relationship between XRCC4 gene's single nucleotide polymorphisms(SNPs) and tumor.
5.Immunosuppressive function of histone deacetylases inhibitors:recent progress
Academic Journal of Second Military Medical University 1982;0(01):-
Histone deacetylases inhibitors(HDACIs)are a group of compound regulating gene expression at transcriptional level.HDACIs can induce protein hyperacetylation and subsequently lead to chromatin remodeling,cell-cycle arrest,cell differentiation and apoptosis,and transcriptional activation and repression.HDACIs demonstrate promising antitumor activity and are presently tested in clinical studies for solid and hematologic malignancies.Cumulating evidence in animal models of immune disorders also suggests immunosuppressive properties of HDACIs,which provides us with new ideas for treating immune disorders and rejection after transplantation.This paper reviews the recent progress of immunosuppressive function induced by HDACIs from the following aspects:immune diseases,T lymphocytes,inflammatory cytokines and dendritic cells.
6.Analysis on reparative process interruption of femoral head necrosis
China Journal of Traditional Chinese Medicine and Pharmacy 2005;0(11):-
The key reason for reparative process interruption of femoral head necrosis is the formation of hardening layer, which make it hard for medicine to act on the necrosis center. The research on formation mechanism of hardening layer is limited and the reason for reparative process interruption is unknown. Based on lots of pathological section and literature data, four hypotheses about the reason for reparative process interruption are proposed, including resource competition, damage of stress, disturbance of nerves and stasis of blood vessel. The internal mechanism of incomplete reparation and chronicity of hardening layer was analyze from different aspects. The four hypotheses provides a new thinking for study the reason for reparative process interruption.
7.The Effects of Vitamin C on the Growth and Apoptosis of Hela Cell
Journal of Medical Research 2006;0(04):-
Objective To discuss the effects of vitamin C in vitro,on human cancer HeLa cell multiplication and apoptosis, in order to promote vitamin C in the tumor treatment application. Methods the morphology changeof cervical cancer Hela cell was observed under the inverted microscope;the effects of vitamin e on Hela cell by MTT assay; cell cyele and weakly perishing rate was analysed rate was analysed by Flow CytoMeter;applying the agarose gelatin electricity swims to analyse weakly perishes in the process the cell gene group DNA change. Results Vitamin C hinders the HeLa cell by the density and the time dependence way to the G0/G1 period, suppresses it to grow and to induce weakly perishes. Conclusions Vitamin C may suppress the HeLa cell to grow, causes the cell to hinder to the G0/G1 period and induces cell weakly perishing.Its reason possibly was HPV E6 protein expression surrenders to restoring the function of P53 gene.
8.Cyclosporine A induced toxicity in kidney tubule epithelial cells (NRK-52E)
Chinese Journal of Organ Transplantation 2003;0(06):-
Objective To investigate and compare cytotoxic effects of cyclosporine A (CsA) treatment in kidney tubule epithelium cells (NRK-52E cells), and whether apoptosis is involved in the CsA-induced toxicity. Methods NRK-52E cells were cultured at 37?℃ in 95?% O 2/5?% CO 2, and were treated with different concentrations of CsA for 48?h.. The damage induced by CsA was characterized by an early cell detachment from culture (by direct counting of adherent cells), lactate dehydrogenase (LDH) release, and the changes in morphology were also observed by a phase-contrast microscope. Assay of apoptosis was done by TUNEL staining. Results CsA treatment induced significant damage in NRK-52E cells, which was demonstrated by obvious signs of cell injury with changes in cell shape, aggregates, and cell loss. A time- and dose-dependent increase in LDH release was also observed for CsA treatment . More than 70?% of the NRK-52E cells treated with 20??g/ml CsA for 48?h were dead. The apoptotic DNA fragments were observed in a population of NRK-52E cells treated with CsA by TUNEL staining, which represented the capacity of CsA to induce apoptosis in NRK-52E cells. Conclusions CsA treatment induced a time- and dose-dependent damage in NRK-52E cells, in which the apoptotic DNA fragments were also observed by TUNEL staining. Thus, the results obtained from the present study suggested that apoptosis, as a possible mechanism, might be involved in the CsA-induced tubulopathy.
9.MR Diagnosis of Brain Metastases from Lung Carcinoma
Acta Medicinae Universitatis Scientiae et Technologiae Huazhong 2000;29(5):464-465
MR appearance of brain metastases from 33 cases of lung carcinoma was reported. The lesions were mainly localized in the cerebrum associated with edema in varying degrees. Squamous cell carcinoma had a tendency to cystic degeneration and adenocarcinoma to bleeding. The low signal rings around the bleeding locus were irregular in T2WI imaging. Enhanced MR could find the lesions that noncontrast-enhanced MR could not. From the above, it was concluded that MRI had an important value in the imaging diagnosis of brain metastases from lung carcinoma.
10.Efficacy of pioglitazone combined with insulin in the trea tment of type 2 diabetes mellitus:a meta-analysis of randomized controlled trials
Chinese Journal of Endocrinology and Metabolism 2015;(7):608-610
The efficacy and safety of pioglitazone in combination with insulin in type 2 diabetic patient were evaluated. CENTRAL, MEDLINE, EMBASE, CBM, CNKI(up to September 2014) were searched by computer. The quality of included randomized controlled trials(RCTs)was assessed according to the Cochrane Collaboration system review, and then meta-analysis was performed using Stata 12. 0. A total of 9 RCTs were included. The results of meta-analyses showed that HbA1C value was lower in the group taking pioglitazone plus insulin than in the group taking insulin without pioglitazone[standard mean difference -0. 48, 95% CI( -0. 55, -0. 40),I2 = 0. 0% ,P = 0. 531], but there were more patients with hypoglycaemic in the pioglitazone plus insulin groups than with insulin without pioglitazone[relative risk 1. 33, 95% CI(1. 21, 1. 46), I2 =75. 4% , P=0. 00].